Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Hormonal Therapy Followed by Radical Prostatectomy
NCT01250717Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jan 2001
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in prostate cancer (PCa), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Pathologic Complete Response. Started Jan 2001; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01250717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250717.